EdgarLookup

ADIAL PHARMACEUTICALS, INC. — All Filings

522 total filings on record

Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.

Overview All Filings Financials Insiders
All 10-K 10-Q 10-Q/A 25-NSE 3 4 4/A 424B3 424B4 424B5 8-A12B 8-A12B/A 8-K 8-K/A ARS CERT CORRESP D DEF 14A DEFA14A DEFR14A DRS DRS/A DRSLTR EFFECT FWP NT 10-Q NT 10-Q/A POS AM PRE 14A PRER14A RW S-1 S-1/A S-3 S-3/A S-8 SC 13D SC 13D/A SC 13G SC 13G/A SCHEDULE 13G UPLOAD
Form Description Accession Number Filed Period
4 0001213900-25-050017 Jun 2, 2025 May 29, 2025
4 0001213900-25-050020 Jun 2, 2025 May 29, 2025
S-3 REGISTRATION STATEMENT 0001213900-25-049473 May 30, 2025
8-K CURRENT REPORT 0001213900-25-049451 May 30, 2025 May 23, 2025
PRE 14A PROXY STATEMENT 0001213900-25-047423 May 23, 2025
8-K FORM 8-K 0001213900-25-043733 May 15, 2025 May 14, 2025
8-K CURRENT REPORT 0001213900-25-043730 May 15, 2025
10-Q QUARTERLY REPORT 0001213900-25-043281 May 14, 2025 Mar 31, 2025
D 0001213900-25-042848 May 14, 2025
8-K CURRENT REPORT 0001213900-25-040724 May 7, 2025 May 2, 2025
424B5 PROSPECTUS SUPPLEMENT 0001213900-25-038910 May 2, 2025
424B5 PROSPECTUS SUPPLEMENT 0001213900-25-038914 May 2, 2025
8-K CURRENT REPORT 0001213900-25-038442 May 1, 2025 Apr 28, 2025
UPLOAD 0000000000-25-003489 Apr 1, 2025
DRSLTR 0001013762-25-003402 Mar 27, 2025
DRS 0001013762-25-003392 Mar 27, 2025
8-K CURRENT REPORT 0001013762-25-000999 Mar 21, 2025 Mar 20, 2025
8-K CURRENT REPORT 0001213900-25-021738 Mar 7, 2025 Mar 5, 2025
8-K CURRENT REPORT 0001213900-25-019779 Mar 4, 2025
10-K ANNUAL REPORT 0001213900-25-019771 Mar 4, 2025 Dec 31, 2024
8-K CURRENT REPORT 0001213900-25-016826 Feb 25, 2025
8-K CURRENT REPORT 0001213900-25-002855 Jan 13, 2025
8-K CURRENT REPORT 0001213900-25-002106 Jan 8, 2025
424B3 PROSPECTUS 0001213900-24-113730 Dec 31, 2024
EFFECT 9999999995-24-003959 Dec 30, 2024
UPLOAD 0000000000-24-014266 Dec 26, 2024
CORRESP 0001213900-24-112607 Dec 26, 2024
S-1 REGISTRATION STATEMENT 0001213900-24-111171 Dec 20, 2024
8-K CURRENT REPORT 0001213900-24-110191 Dec 18, 2024 Dec 13, 2024
S-8 REGISTRATION STATEMENT 0001213900-24-108351 Dec 12, 2024
8-K CURRENT REPORT 0001213900-24-106554 Dec 6, 2024 Dec 5, 2024
4 0001213900-24-106119 Dec 5, 2024
8-K CURRENT REPORT 0001213900-24-099633 Nov 18, 2024 Nov 14, 2024
3 OWNERSHIP DOCUMENT 0001213900-24-099627 Nov 18, 2024 Nov 16, 2024
4 OWNERSHIP DOCUMENT 0001213900-24-099632 Nov 18, 2024 Nov 16, 2024
SC 13G/A 0001172661-24-005115 Nov 14, 2024
10-Q QUARTERLY REPORT 0001213900-24-097519 Nov 13, 2024 Sep 30, 2024
8-K CURRENT REPORT 0001213900-24-096796 Nov 12, 2024
8-K CURRENT REPORT 0001213900-24-094344 Nov 5, 2024 Nov 1, 2024
ARS FORM ARS 0001213900-24-082866 Sep 30, 2024 Dec 31, 2023
DEF 14A PROXY STATEMENT 0001213900-24-082805 Sep 27, 2024 Nov 12, 2024
10-Q QUARTERLY REPORT 0001213900-24-068262 Aug 13, 2024 Jun 30, 2024
10-Q QUARTERLY REPORT 0001213900-24-043023 May 14, 2024 Mar 31, 2024
8-K CURRENT REPORT 0001213900-24-036613 Apr 26, 2024 Apr 24, 2024
424B3 PROSPECTUS 0001213900-24-035359 Apr 23, 2024
EFFECT 9999999995-24-001055 Apr 19, 2024
8-K CURRENT REPORT 0001213900-24-034186 Apr 18, 2024
424B5 PROSPECTUS SUPPLEMENT 0001213900-24-034190 Apr 18, 2024
UPLOAD 0000000000-24-004168 Apr 17, 2024
CORRESP 0001213900-24-033883 Apr 17, 2024